Abstract
The human defensins are a group of cationic antimicrobial peptides that range in size from 2 to 5 kDa and share a common structural motif of six disulphide-linked cysteines. Several naturally occurring human α- and β-defensins have been identified over the past two decades. They have a wide variety of antimicrobial effects, and their potential to avoid the development of resistance to antimicrobial treatment makes them attractive as therapeutic agents. Human defensins have recently been the focus of medical and molecular biology studies due to their promising application in medicine and the pharmaceutical industry. This work aims to provide a comprehensive summary of the current developments of human defensins, including their identification, categorization, molecular features, expression, modes of action, and potential application in medical settings. Current obstacles and future opportunities for using human defensins are also covered. Furthermore, we shed light on the potential of this class as an antiviral agent, particularly against SARS CoV-2, by providing an in silico-based investigation of their plausible mechanisms of action. [Abstract copyright: © 2024. The Author(s).]
Original language | English |
---|---|
Number of pages | 21 |
Journal | Probiotics and Antimicrobial Proteins |
Early online date | 18 Dec 2024 |
DOIs | |
Publication status | E-pub ahead of print - 18 Dec 2024 |
Keywords
- human defensins
- antimicrobial peptides
- SARS CoV-2
- in silico analysis